FIELD: chemistry.
SUBSTANCE: invention relates to crystalline forms of the tartrate of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamide of formula (IV)
, where the crystalline form is an at least 80% pure crystalline form of C, the powder X-ray pattern of which includes peaks corresponding to values d in angstrom - approximately 10.7, approximately 4.84, approximately 4.57 and approximately 3.77. The invention also relates to methods of producing crystalline forms in claim 1, a pharmaceutical composition, a method of administering a compound of formula (I) to a recipient, a method of inhibiting monoamine receptor activity, as well as use of compounds in claim 1.
EFFECT: obtaining a novel compound having monoamine receptor inhibiting or inverse agonist activity.
39 cl, 54 ex, 9 tbl, 7 dwg
| Title |
Year |
Author |
Number |
| N-(4-FLUOROBENZYL)-N-(1-METHYLPIPERIDIN-4-YL)-N'-(2-METHYLPROPYLOXY)PHENYLMETHYL) CARBAMIDE SALTS AND PREPARATION OF SAID SALTS |
2005 |
- Tjugesen Mikkel'
- Shlinger Natali
- Tol'F Bo-Ragnar
- Blatter Fritts
- Bergkhauzen Jorg
|
RU2387643C2 |
| POLYMORPHIC FORM OF N-[(R)-2,3-DIHYDROXYPROPOXY]-3,4-DIFLUORO-2-(2-FLUORO-4-IODOPHENYLAMINO)BENZAMIDE |
2004 |
- Matsikenas Dajnius
- Nanninga Tomas
|
RU2352558C2 |
| METHOD FOR PRODUCING POLYMORPH FORM OF 3-[5-AMINO-4-(3-CYANOBENZOYL)PYRAZOLE-1-YL]-N-CYCLOPROPYL-4-METHYLBENZAMIDE |
2017 |
- Suleiman, Osama
- Perez, Lucia Romero
- Harlacher, Cornelius Stephan
- Jones, Stewart
|
RU2765719C2 |
| METHOD FOR PRODUCING A POLYMORPHIC FORM OF 3-[5-AMINO-4-(3-CYANOBENZOYL)PYRAZOLE-1-YL]-N-CYCLOPROPYL-4-METHYLBENZAMIDE |
2017 |
- Suleiman, Osama
- Perez, Lucia Romero
- Harlacher, Cornelius Stephan
- Jones, Stewart
|
RU2792728C2 |
| N-[5-(AMINOSULPHONYL)-4-METHYL-1,3-THIAZOL-2-YL]-N-METHYL-2-[4-(2-PYRIDINYL)PHENYL]ACETAMIDE MONOHYDRATE |
2012 |
- Schwab, Wilfried
- Birkmann, Alexander
- Voegtli, Kurt
- Haag, Dieter
- Lender, Andreas
- Grunenberg, Alfons
- Keil, Birgit
- Rehse, Joachim
|
RU2669388C1 |
| SOLID FORMS OF (1,1-DIOXO-4-THIOMORPHOLINYL) - [6 - [[3- (4-FLUOROPHENYL) -5-METHYL-4-ISOXAZOLYL] METHOXY] -3-PYRIDINYL] METHANONE |
2012 |
- Dott Paskal
- Grassmann Olaf
- Kammerer Mikhel
- Manns Ioakhim
- Shvitter Urs
- Tomas Endryu
- Vittenbakh Nikol
|
RU2618524C2 |
| MANUFACTURE OF 2-(5-BROMO-4(4-CYCLOPROPYLNAPHTHALEN-1-YL)-4H-1,2,4-TRIAZOL-3-YLTHIO)ACETIC ACID |
2013 |
- Gunik Esmir
- Gelvin Gabriel
|
RU2666549C2 |
| 3,4,4-TRISUBSTITUTED PIPERIDINYL-N-ALKYLCARBOXYLATES AND INTERMEDIATE COMPOUNDS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION |
1994 |
- Skott Alan Frehnk
- Duglas Ehdvard Preter
- Dzheffri Alan Uord
- Dzhon Arnol'D Verner
|
RU2145958C1 |
| POLYMORPHIC FORMS OF (2S)-(4E)-N-METHYL-5-[3-(5-ISOPROPOXYPYRIDIN)YL]-4-PENTEN-2-AMIN FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS |
2007 |
- Dall Gari Moris
- Mun'Os Khulio A.
|
RU2440984C2 |
| 4-METHYL-N-[3-4-METHYLIMIDAZOL-1-YL)-5-TRIFLUOROMETHYLPHENYL]-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)BENZAMIDE SALTS |
2006 |
- Manli Pol U.
- Shi Vehn'Chun
- Satton Pol Allen
- Karpinski Petr Kh.
- Vu Rain
- Monn'E Stefani
- Brotsio Jerg
|
RU2509767C1 |
